Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase 1b Open-Label, Randomized Study Evaluating the Absorption and Systemic Pharmacokinetics of Topically Applied IDP-126 Gel in Comparison With EpiDuo Forte Gel (0.3% Adapalene/ 2.5% BPO) in Subjects With Acne Vulgaris Under Maximal Use Conditions

Trial Profile

A Phase 1b Open-Label, Randomized Study Evaluating the Absorption and Systemic Pharmacokinetics of Topically Applied IDP-126 Gel in Comparison With EpiDuo Forte Gel (0.3% Adapalene/ 2.5% BPO) in Subjects With Acne Vulgaris Under Maximal Use Conditions

Recruiting
Phase of Trial: Phase I

Latest Information Update: 21 Sep 2018

At a glance

  • Drugs IDP 126 (Primary) ; Adapalene/benzoyl peroxide
  • Indications Acne vulgaris
  • Focus Therapeutic Use
  • Sponsors Bausch Health Companies
  • Most Recent Events

    • 07 Sep 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top